GH
Guardant Health, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$172.82
−1.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 13.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -104.06x
- Price / sales
- 19.60x
- Price / cash flow
- -125.23x
Enterprise value
- Enterprise value
- $23.8B
- EV / sales
- 20.15x
- EV / EBITDA
- -57.97x
- EV / EBIT
- -50.68x
- Market cap
- $23.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026